Assetmark, Inc Agilent Technologies, Inc. Transaction History

Assetmark, Inc

$36.2 Billion
Q1 2025

A detailed history of Assetmark, Inc transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 150,171 shares of A stock, worth $17.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

150,171

Previous 135,108 11.15%

Holding current value

$17.1 Million

Previous $18.2 Million 3.21%

% of portfolio

0.05%

Previous 0.05%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$116.69 - $152.6 $1.76 Million - $2.3 Million	15,063 Added 11.15%	150,171 $17.6 Million
Q4 2024 Feb 06, 2025	BUY	$125.69 - $146.56 $4.09 Million - $4.77 Million	32,547 Added 31.73%	135,108 $18.2 Million
Q3 2024 Nov 01, 2024	BUY	$125.42 - $148.48 $4.87 Million - $5.76 Million	38,808 Added 60.87%	102,561 $15.2 Million
Q2 2024 Aug 13, 2024	BUY	$129.63 - $154.64 $2.03 Million - $2.42 Million	15,677 Added 32.61%	63,753 $8.26 Million
Q1 2024 May 06, 2024	BUY	$128.12 - $149.31 $1.9 Million - $2.22 Million	14,861 Added 44.74%	48,076 $7 Million
Q4 2023 Feb 09, 2024	BUY	$101.17 - $139.82 $3.2 Million - $4.43 Million	31,677 Added 2059.62%	33,215 $4.62 Million
Q3 2023 Oct 27, 2023	BUY	$109.73 - $128.47 $7,351 - $8,607	67 Added 4.55%	1,538 $171,000
Q2 2023 Aug 11, 2023	BUY	$114.69 - $141.28 $79,136 - $97,483	690 Added 88.35%	1,471 $176,000
Q1 2023 May 05, 2023	BUY	$131.13 - $159.06 $3,933 - $4,771	30 Added 3.99%	781 $108,000
Q4 2022 Feb 10, 2023	SELL	$125.64 - $157.68 $5,779 - $7,253	-46 Reduced 5.77%	751 $112,000
Q3 2022 Nov 01, 2022	BUY	$115.11 - $142.29 $7,482 - $9,248	65 Added 8.88%	797 $97,000
Q2 2022 Aug 03, 2022	SELL	$112.71 - $135.93 $25,134 - $30,312	-223 Reduced 23.35%	732 $87,000
Q1 2022 May 13, 2022	BUY	$126.0 - $156.48 $42,336 - $52,577	336 Added 54.28%	955 $126,000
Q4 2021 Feb 14, 2022	BUY	$147.95 - $164.3 $86,402 - $95,951	584 Added 1668.57%	619 $99,000
Q2 2021 Aug 16, 2021	SELL	$127.69 - $148.81 $3.61 Million - $4.21 Million	-28,271 Reduced 99.88%	35 $5,000
Q1 2021 May 14, 2021	BUY	$114.99 - $130.12 $61,634 - $69,744	536 Added 1.93%	28,306 $3.6 Million
Q4 2020 Feb 10, 2021	SELL	$100.01 - $119.3 $2.46 Million - $2.93 Million	-24,564 Reduced 46.94%	27,770 $3.29 Million
Q3 2020 Nov 13, 2020	BUY	$88.11 - $103.42 $4.61 Million - $5.41 Million	52,267 Added 78010.45%	52,334 $5.28 Million
Q1 2020 May 12, 2020	SELL	$63.37 - $90.13 $36,311 - $51,644	-573 Reduced 89.53%	67 $5,000
Q4 2019 Feb 11, 2020	BUY	$72.49 - $85.45 $144 - $170	2 Added 0.31%	640 $55,000
Q3 2019 Nov 13, 2019	SELL	$65.59 - $78.07 $983 - $1,171	-15 Reduced 2.3%	638 $49,000
Q2 2019 Aug 14, 2019	SELL	$66.89 - $81.94 $133 - $163	-2 Reduced 0.31%	653 $49,000
Q1 2019 May 14, 2019	SELL	$63.27 - $82.0 $4,618 - $5,986	-73 Reduced 10.03%	655 $53,000
Q4 2018 Feb 13, 2019	SELL	$61.13 - $74.67 $8,313 - $10,155	-136 Reduced 15.74%	728 $49,000
Q3 2018 Nov 13, 2018	SELL	$61.25 - $71.13 $2,021 - $2,347	-33 Reduced 3.68%	864 $61,000
Q2 2018 Aug 01, 2018	BUY	$61.14 - $69.55 $8,253 - $9,389	135 Added 17.72%	897 $55,000
Q1 2018 May 16, 2018	SELL	$65.05 - $74.82 $17,953 - $20,650	-276 Reduced 26.59%	762 $51,000
Q4 2017 Feb 13, 2018	BUY	$64.87 - $70.59 $10,963 - $11,929	169 Added 19.45%	1,038 $70,000
Q3 2017 Nov 08, 2017	SELL	$58.57 - $66.17 $937 - $1,058	-16 Reduced 1.81%	869 $56,000
Q2 2017 Aug 15, 2017	BUY	N/A	42 Added 4.98%	885 $52,000
Q4 2016 Sep 15, 2017	SELL	N/A	-58 Reduced 6.44%	843 $38,000
Q3 2016 Sep 15, 2017	SELL	N/A	-280 Reduced 23.71%	901 $42,000
Q2 2016 Sep 15, 2017	BUY	N/A	359 Added 43.67%	1,181 $52,000
Q1 2016 Sep 15, 2017	SELL	N/A	-4,620 Reduced 84.9%	822 $33,000
Q4 2015 Sep 15, 2017	BUY	N/A	5,442	5,442 $228,000

Others Institutions Holding A

# of Institutions

1,156

Shares Held

256M

Call Options Held

1.09M

Put Options Held

913K

View Full List

About AGILENT TECHNOLOGIES, INC.

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $33.7B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

More about A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account